Yin Liu

7.3k total citations
131 papers, 4.2k citations indexed

About

Yin Liu is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Yin Liu has authored 131 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Molecular Biology, 29 papers in Immunology and 26 papers in Cancer Research. Recurrent topics in Yin Liu's work include CRISPR and Genetic Engineering (13 papers), Advanced biosensing and bioanalysis techniques (10 papers) and Immune Cell Function and Interaction (9 papers). Yin Liu is often cited by papers focused on CRISPR and Genetic Engineering (13 papers), Advanced biosensing and bioanalysis techniques (10 papers) and Immune Cell Function and Interaction (9 papers). Yin Liu collaborates with scholars based in China, United States and Canada. Yin Liu's co-authors include Raphaela Goldbach‐Mansky, Stephen Shaw, Xuming Zhang, Adriana A. de Jesus, Scott Canna, Yíngyún Caì, Hongyu Zhao, Jianfeng Li, Yongqing Chen and Fei Xing and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Yin Liu

122 papers receiving 4.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yin Liu China 36 2.3k 1.1k 881 639 434 131 4.2k
Young Joo Jeon South Korea 36 2.3k 1.0× 806 0.7× 1.0k 1.2× 501 0.8× 200 0.5× 119 3.8k
Glen M. Boyle Australia 42 2.6k 1.1× 898 0.8× 787 0.9× 1.2k 1.9× 298 0.7× 129 5.0k
Ekkehard Weber Germany 39 2.1k 0.9× 841 0.7× 1.2k 1.4× 692 1.1× 346 0.8× 112 4.7k
Hui Feng China 37 2.8k 1.2× 600 0.5× 772 0.9× 1.1k 1.7× 472 1.1× 173 5.0k
Ke Tang China 41 2.9k 1.2× 1.6k 1.4× 1.3k 1.4× 1.1k 1.8× 346 0.8× 105 5.5k
P. Linga Reddy India 12 2.0k 0.8× 1.2k 1.0× 1.0k 1.1× 1.5k 2.3× 171 0.4× 13 4.7k
Yinyin Li China 29 2.1k 0.9× 1.0k 0.9× 365 0.4× 466 0.7× 248 0.6× 114 3.5k
Shaopeng Yuan China 30 1.8k 0.8× 1.5k 1.4× 485 0.6× 694 1.1× 708 1.6× 61 4.7k
Kerri Mowen United States 25 2.5k 1.1× 2.4k 2.1× 351 0.4× 864 1.4× 252 0.6× 33 5.3k

Countries citing papers authored by Yin Liu

Since Specialization
Citations

This map shows the geographic impact of Yin Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yin Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yin Liu more than expected).

Fields of papers citing papers by Yin Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yin Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yin Liu. The network helps show where Yin Liu may publish in the future.

Co-authorship network of co-authors of Yin Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Yin Liu. A scholar is included among the top collaborators of Yin Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yin Liu. Yin Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, You, Yiqing Hu, Xin Zhao, et al.. (2025). Sirolimus-coated versus paclitaxel-coated balloons for bifurcated coronary lesions in the side branch: the SPACIOUS trial. EuroIntervention. 21(6). e307–e317. 2 indexed citations
2.
Liu, Yin, et al.. (2025). Engineered Cas12a-based one-tube detection of DNMT3A R882 H/C mutation in acute myeloid leukemia. Biosensors and Bioelectronics. 286. 117609–117609.
4.
Liu, Yin, et al.. (2024). Identification and Validation of a Novel Tertiary Lymphoid Structures-Related Prognostic Gene Signature in Hepatocellular Carcinoma. World Journal of Oncology. 15(4). 695–710. 1 indexed citations
5.
Hao, Hai, et al.. (2024). Visible Light-Induced Regioselective Intermolecular [2 + 2]-Cycloaddition of Alkyne and 2(1H)-Quinolone Derivatives. The Journal of Organic Chemistry. 89(2). 1353–1360. 3 indexed citations
6.
Dong, Jiangbo, Xinyao Li, Shiying Zhou, et al.. (2023). CRISPR/Cas12a-Powered EC/FL Dual-Mode Controlled-Release Homogeneous Biosensor for Ultrasensitive and Cross-Validated Detection of Messenger Ribonucleic Acid. Analytical Chemistry. 95(32). 12122–12130. 21 indexed citations
8.
Wan, Xiaoling, Jieqiong Chen, Zhixuan Chen, et al.. (2023). Rapid and Sensitive Diagnosis of Leber Hereditary Optic Neuropathy Variants Using CRISPR/Cas12a Detection. Journal of Molecular Diagnostics. 25(8). 540–554. 3 indexed citations
9.
Liu, Yin, Shiying Zhou, Jiangbo Dong, et al.. (2023). Rapid and Ultrasensitive Fluorescence Sensing Platform Based on Nanometer-Sized Metal–Organic Frameworks for Transgenic CaMV 35S Promoter Detection. ACS Applied Nano Materials. 6(8). 7022–7030. 8 indexed citations
10.
Ma, Juan, Shenqing Wang, Chuanfang Zhao, et al.. (2023). Computer‐Aided Discovery of Potent Broad‐Spectrum Vaccine Adjuvants. Angewandte Chemie International Edition. 62(18). e202301059–e202301059. 15 indexed citations
11.
Kuo, Christin S., Spyros Darmanis, Yin Liu, et al.. (2022). Neuroendocrinology of the lung revealed by single-cell RNA sequencing. eLife. 11. 28 indexed citations
12.
Sheng, Dandan, W. F. Mader, Rui Zhang, et al.. (2022). Ccl3 enhances docetaxel chemosensitivity in breast cancer by triggering proinflammatory macrophage polarization. Journal for ImmunoTherapy of Cancer. 10(5). e003793–e003793. 51 indexed citations
13.
Xing, Fei, Yin Liu, Shih-Ying Wu, et al.. (2018). Loss of XIST in Breast Cancer Activates MSN-c-Met and Reprograms Microglia via Exosomal miRNA to Promote Brain Metastasis. Cancer Research. 78(15). 4316–4330. 259 indexed citations
14.
Kim, Hanna, Adriana A. de Jesus, Stephen R. Brooks, et al.. (2018). Development of a Validated Interferon Score Using NanoString Technology. Journal of Interferon & Cytokine Research. 38(4). 171–185. 90 indexed citations
15.
Huang, Tianhe, Yi‐Cheng Shen, Yin Liu, et al.. (2018). Reactive Oxygen Species‐Mediated Tumor Microenvironment Transformation: The Mechanism of Radioresistant Gastric Cancer. Oxidative Medicine and Cellular Longevity. 2018(1). 5801209–5801209. 60 indexed citations
16.
Huang, Liang, Tianwen Chen, Canming Chen, et al.. (2013). Prognostic and predictive value of Phospho-p44/42 and pAKT in HER2-positive locally advanced breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy. World Journal of Surgical Oncology. 11(1). 307–307. 18 indexed citations
17.
Liu, Yin, Ji Liao, Ye Xu, et al.. (2011). A recurrent CHEK2 p.H371Y mutation is associated with breast cancer risk in Chinese women. Human Mutation. 32(9). 1000–1003. 22 indexed citations
18.
Chen, Shangwu, Jie Gao, Jianghai Lin, et al.. (2007). HLA Class II Polymorphisms Associated with The Physiologic Characteristics Defined by Traditional Chinese Medicine: Linking Modern Genetics with An Ancient Medicine. The Journal of Alternative and Complementary Medicine. 13(2). 231–240. 28 indexed citations
19.
Liu, Fei, Yin Liu, Demin Li, et al.. (2002). The transcription co-repressor TLE1 interacted with the intracellular region of gp130 through its Q domain. Molecular and Cellular Biochemistry. 232(1-2). 163–167. 4 indexed citations
20.
Xu, Shi‐Hai, Sheng Guo, Yin Liu, & Lu Zeng. (2001). [Isolation and identification of two steroids from Sinularia inexplicita].. PubMed. 24(1). 34–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026